US 5820873A
· Choi et al.
· 1998
[cited by applicant]
US 7314956B2
· Li et al.
· 2008
[cited by applicant]
US 7404969B2
· Chen et al.
· 2008
[cited by applicant]
US 8017804B2
· Keil et al.
· 2011
[cited by applicant]
US 8058069B2
· Yaworski et al.
· 2011
[cited by applicant]
US 8450298B2
· Mahon et al.
· 2013
[cited by applicant]
US 9326939B2
· Paulson et al.
· 2016
[cited by applicant]
US 9562086B2
· Upton
· 2017
[cited by applicant]
US 20050008689A1
· Semple et al.
· 2005
[cited by applicant]
US 20090221684A1
· Grinstaff et al.
· 2009
[cited by applicant]
US 20100048888A1
· Chen et al.
· 2010
[cited by applicant]
US 20100196277A1
· DeSimone et al.
· 2010
[cited by applicant]
US 20110038941A1
· Lee et al.
· 2011
[cited by applicant]
US 20110165223A1
· Sgouros et al.
· 2011
[cited by applicant]
US 20130171241A1
· Geall
· 2013
[cited by applicant]
US 20140186332A1
· Ezrin et al.
· 2014
[cited by applicant]
US 20140206753A1
· Guild et al.
· 2014
[cited by applicant]
US 20150297749A1
· Hahn et al.
· 2015
[cited by applicant]
CN 101591428
· 2011
[cited by applicant]
CN 103999853
· 2014
[cited by applicant]
EP 3315125
· 2018
[cited by applicant]
EP 3757570
· 2020
[cited by applicant]
EP 3810148
· 2021
[cited by applicant]
EP 3950003
· 2022
[cited by applicant]
JP 2014103108
· 2014
[cited by applicant]
JP 2014529328
· 2014
[cited by applicant]
JP 2015519346
· 2015
[cited by applicant]
JP 2019515016
· 2019
[cited by applicant]
KR 20110090661
· 2011
[cited by applicant]
WO WO2006138380
· 2006
[cited by applicant]
WO WO2010053329
· 2010
[cited by applicant]
WO WO2010129687
· 2010
[cited by applicant]
WO WO2010141069
· 2010
[cited by applicant]
WO WO2012090223
· 2012
[cited by applicant]
WO WO2012170930
· 2012
[cited by applicant]
WO WO2012170952
· 2012
[cited by applicant]
WO WO2013177415
· 2013
[cited by applicant]
WO WO2013177419
· 2013
[cited by applicant]
WO WO2014026283
· 2014
[cited by applicant]
WO WO2014105985
· 2014
[cited by applicant]
WO WO2014106208
· 2014
[cited by applicant]
WO WO2014144196
· 2014
[cited by applicant]
WO WO2015089462
· 2015
[cited by applicant]
WO WO2015148247
· 2015
[cited by applicant]
WO WO2015191693
· 2015
[cited by applicant]
WO WO2016010840
· 2016
[cited by applicant]
WO WO2016094342
· 2016
[cited by applicant]
WO WO2016118697
· 2016
[cited by applicant]
WO WO2016118725
· 2016
[cited by applicant]
WO WO2017048789
· 2017
[cited by applicant]
WO WO2017053713
· 2017
[cited by applicant]
WO WO2017173054
· 2017
[cited by applicant]
WO WO2017180917
· 2017
[cited by applicant]
WO WO2017201091
· 2017
[cited by applicant]
WO WO2017201350
· 2017
[cited by applicant]
WO WO2018029586
· 2018
[cited by applicant]
WO WO2018078053
· 2018
[cited by applicant]
WO WO2019246203
· 2019
[cited by applicant]
WO WO2020051220
· 2020
[cited by applicant]
WO WO2020051223
· 2020
[cited by applicant]
Adams et al., “Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy,”
[cited by applicant]
Akinc et al., “A combinatorial library of lipid-like materials for delivery of RNAi therapeutics,”
[cited by applicant]
Amoasii et al., “Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy,”
[cited by applicant]
Bartsch et al., “Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells,”
[cited by applicant]
Blasco et al., “Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology,”
[cited by applicant]
Bosman et al., “About dendrimers: Structure, physical properties, and applications,”
[cited by applicant]
Boyerinas et al., “The role of let-7 in cell differentiation and cancer,”
[cited by applicant]
Bryantsev et al., “pKa calculations of aliphatic amines, diamines, and aminoamides via density functional theory with a Poisson-Boltzmann continuum solvent model,” J. Phys. Chem. A., 111:4422-4430, 2007.
[cited by applicant]
Carlmark et al., “New methodologies in the construction of dendritic materials,”
[cited by applicant]
Chatani et al., “Facile and Efficient Synthesis of Dendrimers and One-Pot Preparation of Dendritic-Linear Polymer Conjugates via a Single Chemistry: Utilization of Kinetically Selective Thiol-Michael Addition Reactions,”
[cited by applicant]
Cheng and Lee, “The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery,”
[cited by applicant]
Cheng et al., “Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I,”
[cited by applicant]
Cheng et al., “Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing,”
[cited by applicant]
Chew et al., “A multifunctional AAV-CRISPR-Cas9 and its host response,”
[cited by applicant]
Coelho et al., “Safety and efficacy of RNAi therapy for transthyretin amyloidosis,”
[cited by applicant]
Cong et al., “Multiplex genome engineering using CRISPR/Cas systems,”
[cited by applicant]
Cui et al., “Correlation of the cytotoxic effects of cationic lipids with the headgroups,”
[cited by applicant]
Dahlman et al., “In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight,”
[cited by applicant]
Derosa et al., “Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system,”
[cited by applicant]
Dong et al., “Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates,”
[cited by applicant]
Dong et al., “Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo,”
[cited by applicant]
Doudna & Charpentier, “Genome editing. The new frontier of genome engineering with CRISPR-Cas9,”
[cited by applicant]
Duncan and Izzo, “Dendrimer biocompatibility and toxicity,”
[cited by applicant]
Ex parte Rolf Bergmann, Maria Lundqvist, Stig Mannberg, Bjorn Lundgren, and Robert Shimizu, Board of Patent Appeals and Interferences, Appeal 2011-013450, Feb. 1, 2012.
[cited by applicant]
Extended European Search Report issued in European Application No. 16847193.6, mailed Feb. 19, 2019.
[cited by applicant]
Extended European Search Report issued in European Application No. 19857774.4, mailed Jun. 7, 2022.
[cited by applicant]
Extended European Search Report issued in European Application No. 19858575.4, mailed Sep. 12, 2022.
[cited by applicant]
Extended European Search Report issued in European Application No. 19822888.4, mailed May 6, 2022.
[cited by applicant]
Extended European Search Report issued in European Application No. 17800042.8, mailed Dec. 19, 2019.
[cited by applicant]
Fenton et al., “Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery,”
[cited by applicant]
Fenton et al., “Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to B lymphocytes,”
[cited by applicant]
Finn et al., “A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing,”
[cited by applicant]
Franc and Kakkar, ““Click” methodologies: efficient, simple and greener routes to design dendrimers,”
[cited by applicant]
Gilleron et al., “Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape,”
[cited by applicant]
Gillies and Fréchet, “Designing macromolecules for therapeutic applications: Polyester dendrimer-poly(ethylene oxide) ”bow-tie“ hybrids with tunable molecular weight and architecture,”
[cited by applicant]
Grayson and Fréchet, “Convergent dendrons and dendrimers: From synthesis to applications,”
[cited by applicant]
Grompe et al., “Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I,”
[cited by applicant]
Gustafson et al., “Nanoparticle Uptake: The Phagocyte Problem,”
[cited by applicant]
Hafez et al., “On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids,”
[cited by applicant]
Hajj & Whitehead, “Tools for translation: non-viral materials for therapeutic mRNA delivery,”
[cited by applicant]
Hao et al., “Rapid Synthesis of a Lipocationic Polyester Library via Ring-Opening Polymerization of Functional Valerolactones for Efficacious siRNA Delivery,”
[cited by applicant]
Harvie et al., “Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation,”
[cited by applicant]
Hendel et al., “Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells,”
[cited by applicant]
Hoyle et al., “Thiol-click chemistry: a multifaceted toolbox for small molecule and polymer synthesis,”
[cited by applicant]
Jarzbińska et al., “A Single Methylene Group in Oligoalkylamine-Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery,”
[cited by applicant]
Jayaraman et al., “Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo,”
[cited by applicant]
Jiang et al., “A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo,”
[cited by applicant]
Jinek et al., “A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity,”
[cited by applicant]
Kaczmarek et al., “Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs,”
[cited by applicant]
Kanasty et al., “Delivery materials for siRNA therapeutics,”
[cited by applicant]
Kang et al., “Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides,”
[cited by applicant]
Kauffman et al., “Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs,”
[cited by applicant]
Khan et al., “Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo,”
[cited by applicant]
Killops et al., “Robust, efficient, and orthogonal synthesis of dendrimers via thiol-ene “click” chemistry,”
[cited by applicant]
Kormann et al., “Expression of therapeutic proteins after delivery of chemically modified mRNA in mice,”
[cited by applicant]
Lee et al., “Designing dendrimers for biological applications,”
[cited by applicant]
Leung et al., “Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core,”
[cited by applicant]
Li and Szoka, “Lipid-based nanoparticles for nucleic acid delivery,”
[cited by applicant]
Li et al., “A biomimetic lipid library for gene delivery through thiol-yne click chemistry,”
[cited by applicant]
Li et al., “An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo,”
[cited by applicant]
Li et al., “Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA,”
[cited by applicant]
Love et al., “Lipid-like materials for low-dose, in vivo gene silencing,”
[cited by applicant]
Lowe, “mRNA vaccines; what happens,” located at https://www.science.org/content/blog-post/mrna-vaccines-what-happens, accessed Jan. 15, 2022, originally published Jan. 21, 2021.
[cited by applicant]
Lowe, “RNA vaccines and their lipids,” In the Pipeline, https://blogs.sciencemag.org/pipeline/archives/2021/01/11/rna-vaccines-and-their-lipids, accessed Aug. 19, 2021, originally published Jan. 11, 2021.
[cited by applicant]
Lowe, “What mRNA is good for, and what it maybe isn't,” https://www.science.org/content/blog-post/what-mrna-good-and-what-it-maybe-isn-t accessed Jan. 15, 2022, originally published Jun. 29, 2021.
[cited by applicant]
Lu et al., “Toxicity of cationic lipids and cationic polymers in gene delivery,”
[cited by applicant]
Ma et al., “Facile synthesis of polyester dendrimers from sequential click coupling of asymmetrical monomers,”
[cited by applicant]
Maddalo et al., “In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system,”
[cited by applicant]
Mali et al., “RNA-guided human genome engineering via Cas9,”
[cited by applicant]
Marshall et al., “Cationic lipid structure and formulation considerations for optimal gene transfection of the lung,”
[cited by applicant]
Miller et al., “Non-viral CRISPR/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of Vas9 mRNA and sgRNA,”
[cited by applicant]
Murat and Grest, “Molecular dynamics study of dendrimer molecules in solvents of varying quality,”
[cited by applicant]
Nelson et al., “Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo,” ACS Nano, 7:8870-8880, 2013.
[cited by applicant]
Notice of Allowance issued in U.S. Appl. No. 15/265,064, mailed Oct. 1, 2021.
[cited by applicant]
Notice of Allowance issued in U.S. Appl. No. 17/191,895, mailed Sep. 1, 2021.
[cited by applicant]
Office Action issued in British Application No. 2104769.1, mailed Jun. 1, 2021.
[cited by applicant]
Office Action issued in British Application No. 2104777.4, mailed Jun. 1, 2021.
[cited by applicant]
Office Action issued in British Application No. GB 2219700.8, mailed Feb. 3, 2023.
[cited by applicant]
Office Action issued in British Application No. GB2100678.8, mailed Jun. 11, 2021.
[cited by applicant]
Office Action issued in British Application No. GB2104777.4, mailed Mar. 2, 2022.
[cited by applicant]
Office Action issued in British Application No. GB2111272.7, mailed Mar. 2, 2022.
[cited by applicant]
Office Action issued in Chinese Application No. 201980070622.2, mailed Nov. 28, 2023, and English translation thereof.
[cited by applicant]
Office Action issued in Japanese Application No. 2018-513463, mailed Sep. 7, 2020.
[cited by applicant]
Office Action issued in Japanese Application No. 2021-536681, mailed Nov. 9, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 15/265,064, mailed Aug. 3, 2020.
[cited by applicant]
Office Action issued in U.S. Appl. No. 15/597,063, mailed Apr. 22, 2020.
[cited by applicant]
Office Action issued in U.S. Appl. No. 15/597,063, mailed Aug. 22, 2019.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/124,462, mailed Apr. 22, 2021.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/124,462, mailed Apr. 6, 2023.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/124,462, mailed Jul. 12, 2021.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/124,462, mailed Jun. 22, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/124,462, mailed Jan. 25, 2024.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/124,462, mailed Nov. 15, 2021.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/124,462, mailed Sep. 20, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/191,895, mailed Jun. 16, 2021.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/191,975, mailed Aug. 25, 2021.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/191,975, mailed Dec. 14, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/191,975, mailed Feb. 11, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/191,975, mailed Jul. 26, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/191,975, mailed Nov. 1, 2021.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/572,615, mailed Mar. 24, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/572,615, mailed May 5, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/839,699, mailed Sep. 6, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 17/929,704, mailed Oct. 28, 2022.
[cited by applicant]
Office Action issued in U.S. Appl. No. 18/534,974, mailed Feb. 16, 2024.
[cited by applicant]
Pankowicz et al., “Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia,”
[cited by applicant]
Pardi et al., “Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes,”
[cited by applicant]
Patel et al., “Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA,”
[cited by applicant]
PCT International Preliminary Report on Patentability issued in International Application No. PCT/US2019/049552, mailed Mar. 18, 2021.
[cited by applicant]
PCT International Preliminary Report on Patentability issued in International Application No. PCT/US2019/049565, mailed Mar. 18, 2021.
[cited by applicant]
PCT International Search Report and Written Opinion issued in International Application No. PCT/US2019/037904, mailed Oct. 2, 2019.
[cited by applicant]
PCT International Search Report and Written Opinion issued in International Application No. PCT/US2016/051648, mailed Feb. 7, 2017.
[cited by applicant]
PCT International Search Report and Written Opinion issued in International Application No. PCT/US2019/049552, mailed Dec. 30, 2019.
[cited by applicant]
PCT International Search Report and Written Opinion issued in International Application No. PCT/US2019/049565, mailed Feb. 7, 2020.
[cited by applicant]
PCT International Search Report and Written Opinion issued in International Application No. PCT/US2017/032967, mailed Aug. 11, 2017.
[cited by applicant]
Percec et al., “Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures,”
[cited by applicant]
Petsch et al., “Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection,”
[cited by applicant]
Ramaswamy et al., “Systemic delivery of factor IX messenger RNA for protein replacement therapy,”
[cited by applicant]
Regnaud, “Design and synthesis of dendrimers by combination of ‘click’ chemistry and A3-coupling,” Thesis, McGill University, pp. 1-67, 2013.
[cited by applicant]
Richner et al., “Modified mRNA Vaccines Protect against Zika Virus Infection,”
[cited by applicant]
Sahay et al., “Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling,”
[cited by applicant]
Sahin et al., “mRNA-based therapeutics—developing a new class of drugs,”
[cited by applicant]
Sander & Joung, “CRISPR-Cas systems for editing, regulating and targeting genomes,” Nat. Biotechnol., 32:347-355, 2014.
[cited by applicant]
Schaffert et al., “Solid-phase synthesis of sequence-defined T-, i-, and U-shape polymers for pDNA and siRNA delivery,”
[cited by applicant]
Semple et al., “Rational design of cationic lipids for siRNA delivery,”
[cited by applicant]
Shobaki et al., “Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting,”
[cited by applicant]
Siegwart et al., “Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery,”
[cited by applicant]
Staahl et al., “Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes,”
[cited by applicant]
Stiriba et al., “Dendritic polymers in biomedical applications: From potential to clinical use in diagnostics and therapy,”
[cited by applicant]
Sun et al., “Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing,”
[cited by applicant]
Sundaram et al., “Reversibly switchable polymer with cationic/zwitterionic/anionic behavior through synergistic protonation and deprotonation,”
[cited by applicant]
Tabebordbar et al., “In vivo gene editing in dystrophic mouse muscle and muscle stem cells,” Science, 351:407-411, 2016.
[cited by applicant]
Taratula et al., “Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery,”
[cited by applicant]
Tousignant et al., “Comprehensive analysis of the acute toxicity systemic administration of cationic lipid:plasmid DNA complexes in mice,”
[cited by applicant]
Uchida et al., “Modulated protonation of side chain aminoethylene repeats in N-substituted polyaspartamides promotes mRNA transfection,”
[cited by applicant]
Wang et al., “Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice,” Nat. Biotechnol., 36(9):839-842, 2018.
[cited by applicant]
Wang et al., “CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery,”
[cited by applicant]
Whitehead et al., “Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity,”
[cited by applicant]
Wilhelm et al., “Analysis of nanoparticle delivery to tumours,” Nat. Rev. Mater., 1:16014, 2016.
[cited by applicant]
Wittrup et al., “Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown,”
[cited by applicant]
Wood, “Traumatic brain injury induces transmissible tau pathology,”
[cited by applicant]
Wu et al., “Dendrimers in medicine: Therapeutic concepts and pharmaceutical challenges,”
[cited by applicant]
Wu et al., “Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(I)-catalyzed ligation of azides and alkynes,”
[cited by applicant]
Wu et al., “RNAi therapies: drugging the undruggable,”
[cited by applicant]
Xu et al., “Fluorescent water-soluble perylenediimide-cored cationic dendrimers: synthesis, optical properties, and cell uptake,”
[cited by applicant]
Xue et al., “CRISPR-mediated direct mutation of cancer genes in the mouse liver,” Nature, 514:380-384, 2014.
[cited by applicant]
Yan et al., “Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells,”
[cited by applicant]
Yan et al., “Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers,”
[cited by applicant]
Yin et al., “Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype,”
[cited by applicant]
Yin et al., “Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing,” Nat. Biotechnol., 35:1179-1187, 2017.
[cited by applicant]
Yin et al., “Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo,”
[cited by applicant]
Yu et al., “An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo,”
[cited by applicant]
Yung et al., “Lipid nanoparticles composed of quaternary amine-tertiary amine cationic lipid combination (QTsome) for therapeutic delivery of antimiR-21 for lung cancer,”
[cited by applicant]
Zelphati and Szoca, “Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids,”
[cited by applicant]
Zhang et al., “Biodegradable amino-ester nanomaterials for Cas9 mRNA delivery in vitro and in vivo,”
[cited by applicant]
Zhang et al., “Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration,”
[cited by applicant]
Zhang et al., “The Polyploid State Plays a Tumor-Suppressive Role in the Liver,”
[cited by applicant]
Zhou et al., “Balancing biocompatibility, internalization and pharmacokinetics of polycations/siRNA by structuring the weak negative charged ternary complexes with hyaluronic acid,”
[cited by applicant]
Zhou et al., “Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model,”
[cited by applicant]
Zhou et al., “Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model,” Supporting Information,
[cited by applicant]
Zhou et al., “PAMAM dendrimers for efficient siRNA delivery and potent gene silencing,”
[cited by applicant]
Zuris et al., “Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo,” Nat. Biotechnol., 33:73-80, 2015.
[cited by applicant]